Although senior leadership has been re-organized, the actual consistency and interactivity of the team remains stable. In fact, Dr. DiPaola was appointed as Director of CINJ following multiple appointments at CINJ including Co-Leader of the Prostate Program, Chief of Medical Oncology and Associate Director for Clinical Science. Dr. Edmund Lattime, a prior Associate Director, was appointed to the position of Deputy Director in 2008 by Dr. DiPaola. Dr. Joseph R. Bertino remains as Chief Scientific Officer. Dr. Michael Reiss continues as Associate Director for Translational Science and has appropriately assumed oversight of all basic science and translational shared resources. Dr. Eileen White, a Program Leader since 2004, was appointed Associate Director for Basic Science and, following a move of her laboratories to the main CINJ building in New Brunswick, increased basic science mentorship at CINJ. Dr. Joseph Aisner is Associate Director for Clinical Science as in the 2004 review, and Dr. Susan Goodin has been appointed Assistant Director for Clinical Science and Director ofthe Office of Human Research Services. Stability in administration also remains, as Ms. Linda Barker continues as Associate Director for Administration and Planning. As a new leader. Dr. Helmut Zarbl was appointed Associate Director for Public Health Science, overseeing CINJ's efforts in prevention, control, and population science. Salary support for these individuals is requested only for the effort attributable to research-related activities.
The senior leadership supports the mission ofthe Cancer Institute of New Jersey (CINJ) as a National Cancer institute (NCI)-designated comprehensive cancer center to increase scientific depth and breadth in basic, clinical and public health sciences.
|DiPaola, Robert S; Chen, Yu-Hui; Bubley, Glenn J et al. (2015) A national multicenter phase 2 study of prostate-specific antigen (PSA) pox virus vaccine with sequential androgen ablation therapy in patients with PSA progression: ECOG 9802. Eur Urol 68:365-71|
|Mukherjea, Arnab; Wackowski, Olivia A; Lee, Youn Ok et al. (2014) Asian American, Native Hawaiian and Pacific Islander tobacco use patterns. Am J Health Behav 38:362-9|
|Wan, Liling; Lu, Xin; Yuan, Salina et al. (2014) MTDH-SND1 interaction is crucial for expansion and activity of tumor-initiating cells in diverse oncogene- and carcinogen-induced mammary tumors. Cancer Cell 26:92-105|
|Steinberg, Michael B; Zimmermann, Mia Hanos; Delnevo, Cristine D et al. (2014) E-cigarette versus nicotine inhaler: comparing the perceptions and experiences of inhaled nicotine devices. J Gen Intern Med 29:1444-50|
|Simhadri, Srilatha; Peterson, Shaun; Patel, Dharm S et al. (2014) Male fertility defect associated with disrupted BRCA1-PALB2 interaction in mice. J Biol Chem 289:24617-29|
|Chandran, Urmila; McCann, Susan E; Zirpoli, Gary et al. (2014) Intake of energy-dense foods, fast foods, sugary drinks, and breast cancer risk in African American and European American women. Nutr Cancer 66:1187-99|
|Zimmermann, M H; Richardson, D L; Manderski, M T B et al. (2014) Relighting behaviour among cigarette smokers seeking treatment: implications for tobacco treatment and policy. Int J Clin Pract 68:1358-63|
|Zheng, Hanqiu; Shen, Minhong; Zha, Yin-Lian et al. (2014) PKD1 phosphorylation-dependent degradation of SNAIL by SCF-FBXO11 regulates epithelial-mesenchymal transition and metastasis. Cancer Cell 26:358-73|
|Gong, Zhihong; Ambrosone, Christine B; McCann, Susan E et al. (2014) Associations of dietary folate, Vitamins B6 and B12 and methionine intake with risk of breast cancer among African American and European American women. Int J Cancer 134:1422-35|
|Faiena, Izak; Singer, Eric A; Pumill, Chris et al. (2014) Cytoreductive prostatectomy: evidence in support of a new surgical paradigm (Review). Int J Oncol 45:2193-8|
Showing the most recent 10 out of 191 publications